Mengyang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mengyang Liu has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
Guilin Peng
Department of Organ Transplantation, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
2 shared publications- Bastian Grande
University Hospital Zurich, Zurich, Switzerland
1 shared publication Chao Yang
Department of Organ Transplantation, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
1 shared publication- Chao Yang
Department of Blood Transfusion, The General Hospital of the PLA Rocket Force, Beijing, China
1 shared publication - Christina C. Kao
Section of Pulmonary, Critical Care, and Sleep, Department of Medicine, Baylor College of Medicine, Houston, USA
1 shared publication - Cong Li
Fudan University
1 shared publication
Latest Publications
- Open Access
- 24 July 2024
- Published by Elsevier in JTCVS Techniques
- Vol. 27, 207-210
A novel bilateral lobar lung transplantation: End-to-side pulmonary artery reconstruction in left-to-right inverted split-lobe lung transplantation
- 24 July 2024
- Published by Elsevier in JTCVS Techniques
- Vol. 27, 207-210
Open AccessA novel bilateral lobar lung transplantation: End-to-side pulmonary artery reconstruction in left-to-right inverted split-lobe lung transplantation
- 31 October 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 963, 176164
Anemoside B4 ameliorates dextran sulfate sodium (DSS)-induced colitis through inhibiting NLRP3 inflammasome and modulating gut microbiota
- 31 October 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 963, 176164
Anemoside B4 ameliorates dextran sulfate sodium (DSS)-induced colitis through inhibiting NLRP3 inflammasome and modulating gut microbiota
- 5 February 2022
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 172, 89-100
Discovery in polyethylene glycol immunogenicity: The characteristic of intergenerational inheritance of anti-polyethylene glycol IgG
- 5 February 2022
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 172, 89-100
Discovery in polyethylene glycol immunogenicity: The characteristic of intergenerational inheritance of anti-polyethylene glycol IgG
- Open Access
- 1 March 2021
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 10 (3) , 1588-1593
Pulmonary fibrosis combined with lung cancer following lung transplantation: should we do more?
Currently, lung transplantation is the standard of care for patients with end-stage lung disease, with interstitial lung disease (ILD) being the most common reason in the recent years In the other hand, in cases where stage II and III lung cancer have been identified following lung transplantation, long-term survival outcomes are poor when compared to lung cancer patients that have not received a lung transplant because the use of immunosuppressant and the problem of rejection and infection and the treatment of recurrence and so on. However, there is no statistical difference observed in stage I (pT1N0M0) patients. In this paper we report about a patient with ILD receiving left lung transplantation in the early time. A lesion of the right lung which was considered the normal ILD tissue and without enough attention. Post-transplant it showed progress and finally the whole right lung (native lung) was occupied by the tumor. Some ground glass changes could also be found in the transplanted lung several months later. A secondary lung transplant was performed for this patient, and there has been no postoperative recurrence thus far. For lung transplant patients with high-risk factors, effective surveillance methods are required for the early detection of lung cancer.
- 1 March 2021
- Published by AME Publishing Company in Translational Lung Cancer Research
- Vol. 10 (3) , 1588-1593
Open AccessPulmonary fibrosis combined with lung cancer following lung transplantation: should we do more?
Currently, lung transplantation is the standard of care for patients with end-stage lung disease, with interstitial lung disease (ILD) being the most common reason in the recent years In the other hand, in cases where stage II and III lung cancer have been identified following lung transplantation, long-term survival outcomes are poor when compared to lung cancer patients that have not received a lung transplant because the use of immunosuppressant and the problem of rejection and infection and the treatment of recurrence and so on. However, there is no statistical difference observed in stage I (pT1N0M0) patients. In this paper we report about a patient with ILD receiving left lung transplantation in the early time. A lesion of the right lung which was considered the normal ILD tissue and without enough attention. Post-transplant it showed progress and finally the whole right lung (native lung) was occupied by the tumor. Some ground glass changes could also be found in the transplanted lung several months later. A secondary lung transplant was performed for this patient, and there has been no postoperative recurrence thus far. For lung transplant patients with high-risk factors, effective surveillance methods are required for the early detection of lung cancer.
- Open Access
- 25 February 2016
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 18 (1)
Cannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury
- 25 February 2016
- Published by Physicians Postgraduate Press, Inc in The Primary Care Companion For CNS Disorders
- Vol. 18 (1)
Open AccessCannabinoid Hyperemesis Syndrome Associated With Compulsive Showering and Acute Kidney Injury